These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10099035)

  • 1. Hepatic encephalopathy and role of antibenzodiazepines.
    Hammond JB; Ahmad F
    Am J Ther; 1998 Jan; 5(1):33-6. PubMed ID: 10099035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.
    Als-Nielsen B; Kjaergard LL; Gluud C
    Cochrane Database Syst Rev; 2001; (4):CD002798. PubMed ID: 11687160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benzodiazepine receptor antagonists for hepatic encephalopathy.
    Als-Nielsen B; Gluud LL; Gluud C
    Cochrane Database Syst Rev; 2004; (2):CD002798. PubMed ID: 15106178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endozepines in recurrent stupor.
    Cortelli P; Avallone R; Baraldi M; Zeneroli ML; Mandrioli J; Corsi L; Riva R; Tinuper P; Lugaresi E; Baruzzi A; Montagna P
    Sleep Med Rev; 2005 Dec; 9(6):477-87. PubMed ID: 16233983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of flumazenil.
    Whitwam JG; Amrein R
    Acta Anaesthesiol Scand Suppl; 1995; 108():3-14. PubMed ID: 8693922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do benzodiazepine ligands contribute to hepatic encephalopathy?
    Jones EA; Basile AS; Yurdaydin C; Skolnich P
    Adv Exp Med Biol; 1993; 341():57-69. PubMed ID: 8116487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain GABA and benzodiazepine receptors in hepatic encephalopathy.
    Butterworth RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():137-40. PubMed ID: 19256153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of benzodiazepine-receptor antagonists and partial inverse agonists on acute hepatic encephalopathy in the rat.
    Bosman DK; van den Buijs CA; de Haan JG; Maas MA; Chamuleau RA
    Gastroenterology; 1991 Sep; 101(3):772-81. PubMed ID: 1650320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzodiazepine antagonist in the treatment of human hepatic encephalopathy.
    Ferenci P; Grimm G
    Adv Exp Med Biol; 1990; 272():255-65. PubMed ID: 2103692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial.
    Pomier-Layrargues G; Giguère JF; Lavoie J; Perney P; Gagnon S; D'Amour M; Wells J; Butterworth RF
    Hepatology; 1994 Jan; 19(1):32-7. PubMed ID: 8276366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.
    Basile AS; Hughes RD; Harrison PM; Murata Y; Pannell L; Jones EA; Williams R; Skolnick P
    N Engl J Med; 1991 Aug; 325(7):473-8. PubMed ID: 1649403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flumazenil: a benzodiazepine antagonist.
    Hoffman EJ; Warren EW
    Clin Pharm; 1993 Sep; 12(9):641-56; quiz 699-701. PubMed ID: 8306565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances.
    Jones EA; Skolnick P; Gammal SH; Basile AS; Mullen KD
    Ann Intern Med; 1989 Apr; 110(7):532-46. PubMed ID: 2538099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electroencephalographic study of the effect of a benzodiazepine antagonist in hepatic encephalopathy].
    Pidoux B; Zylberberg P; Valla D; Opolon P
    Neurophysiol Clin; 1989 Dec; 19(6):469-76. PubMed ID: 2559309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flumazenil in the treatment of portal systemic encephalopathy--an overview.
    Gyr K; Meier R
    Intensive Care Med; 1991; 17 Suppl 1():S39-42. PubMed ID: 1774410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepine receptor antagonism improves reaction time in latent hepatic encephalopathy.
    Gooday R; Hayes PC; Bzeizi K; O'Carroll RE
    Psychopharmacology (Berl); 1995 Jun; 119(3):295-8. PubMed ID: 7675964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.
    Rothstein JD; Olasmaa M
    Neurochem Res; 1990 Feb; 15(2):193-7. PubMed ID: 2159124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
    Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M
    Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persisting benzodiazepine metabolites responsible for the reaction to the benzodiazepine antagonist flumazenil in patients with hepatic encephalopathy.
    Meier R; Gyr K; Scholer A
    Gastroenterology; 1991 Jul; 101(1):274-5. PubMed ID: 2044919
    [No Abstract]   [Full Text] [Related]  

  • 20. [Benzodiazepine antagonists in the treatment of heptic encephalopathy].
    Ferenci P; Grimm G
    Leber Magen Darm; 1989 Dec; 19(6):322-5. PubMed ID: 2575692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.